Innovations and Smart Approaches in Safe Prescribing
In 2019, an estimated 10.1 million Americans aged 12 years or older misused opioids in the past year. Specifically, 9.7 million people misused prescription pain relievers.
The origin of this epidemic began in the 1990s when the pharmaceutical industry promoted the use of opioids as a nonaddictive solution to treat pain. Since then, nearly 500,000 people have died from an opioid overdose.
This program aims to reengage physicians with the CDC's guidelines for opioid safety by using real scenarios, case reviews, and at least five achievable, behavior changing objectives. The program also addresses cultural linguistic competency and implicit bias.
|Course ID #:||TJE 221101.0||Issue Date:||8/3/2022||Expiration Date:||8/3/2025|
After completing this activity, learners will be able to:
- Evaluate one's own internal stigma and biases towards opioids and those with OUD.
- De-stigmatize the language used when referring to addiction and prioritize care and respect interactions with patients.
- Utilize the CDC guidelines for prescribing opioids, and alternative pain medication in the treatment and management of patients in pain.
- Use non-pharmacological and pharmacological alternatives to opioids.
- Apply CURES 2.0 for opioids and evaluate current usages of CURES.
- Examine multimodal approaches for chronic pain, including physical, psycho-behavioral, procedural, and pharmacological modalities.
- Implement strategies for recognizing Substance Use Disorder (SUD) and Opioid Use Disorder (OUD).
- Screen for fentanyl in all urine drug screens to reduce fentanyl related mortality.
No individual in a position to control or influence the content of this activity has reported relevant financial relationships with commercial interests. No commercial support was provided for this activity.
The information and guidelines contained in this activity are generalized and may not apply to all practice situations. We recommend that legal advice be obtained from a qualified attorney for specific application to your practice. The information is intended for educational purposes and should be used as a reference guide only.
Nathan Painter, MD, PharmD, UCSD Skaggs School of Pharmacy, Clinical Pharmacist in Family Medicine
Roneet Lev, MD, Emergency and Addiction Physician, Scripps Mercy Hospital
Bianca Tribuzio, DO, Sharp Rees-Stealy Medical Group
Christy Cotner, DNP, Riverside Medical Clinic
Nick Mellos, MD, VA San Diego Healthcare System
Wilma Wooten, MD, San Diego Health, and Human Services Agency
Yalonda Hutchings, MD, San Diego Health, and Human Services Agency
Danyte Mockus-Valenzuela, PhD, MPH, San Diego Health, and Human Services Agency
Deirdre Brown, MPH, San Diego Health, and Human Services Agency
Johanna Lackner, MPH, MSW, Senior Director, Continuing Professional Development, Department of Patient Safety and Risk Management, The Doctors Company
Continuing Education Credit
The Doctors Company is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical educational activities for physicians.
The Doctors Company designates this activity for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Doctors Company and Champions for Health. The Doctors Company is accredited by the ACCME to provide continuing medical education for physicians.
Complies with State Requirements
Please SEE the Federation of State Medical Boards overview of Continuing Medical Education requirements by State.
If you have questions, contact email@example.com or call 800.421.2368.
Visit our Resource document for this program.